Eprosartan |
Teveten |
Eprosartan Teveten Eprosartan Systematic (IUPAC) name 4-[[2-butyl-5-(2-carboxy-3-thiophen-2-yl-prop-1-enyl)- imidazol-1-yl]methyl]benzoic acid Identifiers CAS number 133040-01-4 ATC code C09CA02 ? PubChem 9670 DrugBank APRD00950 Chemical data Formula C23H24N2O4S Mol. weight 424.514 g/mol Pharmacokinetic data Bioavailability ? Metabolism ? Half life 5 to 9 hours. Excretion ? Therapeutic considerations Pregnancy cat. ? L ...
Wikipedia - [full article]
Eprosartan Clinical Trials
- Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives with Type II Diabetes
ClinicalTrials.gov Identifier: NCT00160160 - Completed
hypertension, type 2 diabetes
- The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension
ClinicalTrials.gov Identifier: NCT00438945 - Recruiting
Essential Hypertension
- The Effect of Eprosartan on Hormones and Kidney Function in Healthy Humans.
ClinicalTrials.gov Identifier: NCT00409903 - Completed
Healthy
Resources
- Eprosartan (Drug Digest)
- Teveten (Drug Digest)

Not Signed In -


